1. Review of tracer kinetic models in evaluation of gliomas using dynamic contrast-enhanced imaging
- Author
-
Jianan Zhou, Zujun Hou, Chuanshuai Tian, Zhengyang Zhu, Meiping Ye, Sixuan Chen, Huiquan Yang, Xin Zhang, and Bing Zhang
- Subjects
glioma ,dynamic contrast-enhanced ,tracer kinetic model ,diagnosis ,treatment response ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Glioma is the most common type of primary malignant tumor of the central nervous system (CNS), and is characterized by high malignancy, high recurrence rate and poor survival. Conventional imaging techniques only provide information regarding the anatomical location, morphological characteristics, and enhancement patterns. In contrast, advanced imaging techniques such as dynamic contrast-enhanced (DCE) MRI or DCE CT can reflect tissue microcirculation, including tumor vascular hyperplasia and vessel permeability. Although several studies have used DCE imaging to evaluate gliomas, the results of data analysis using conventional tracer kinetic models (TKMs) such as Tofts or extended-Tofts model (ETM) have been ambiguous. More advanced models such as Brix’s conventional two-compartment model (Brix), tissue homogeneity model (TH) and distributed parameter (DP) model have been developed, but their application in clinical trials has been limited. This review attempts to appraise issues on glioma studies using conventional TKMs, such as Tofts or ETM model, highlight advancement of DCE imaging techniques and provides insights on the clinical value of glioma management using more advanced TKMs.
- Published
- 2024
- Full Text
- View/download PDF